Of mice and men: therapeutic mTOR inhibition in polycystic kidney disease
- PMID: 20133481
- PMCID: PMC4473250
- DOI: 10.1681/ASN.2010010072
Of mice and men: therapeutic mTOR inhibition in polycystic kidney disease
Comment on
-
Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1.J Am Soc Nephrol. 2010 Mar;21(3):489-97. doi: 10.1681/ASN.2009040421. Epub 2010 Jan 14. J Am Soc Nephrol. 2010. PMID: 20075061 Free PMC article.
References
-
- The European Polycystic Kidney Disease Consortium: The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16: Cell 77: 881–894, 1994 - PubMed
-
- Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, Reynolds DM, Cai Y, Gabow PA, Pierides A, Kimberling WJ, Breuning MH, Deltas CC, Peters DJ, Somlo S: PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272: 1339–1342, 1996 - PubMed
-
- Ong AC, Harris PC: Molecular pathogenesis of ADPKD: The polycystin complex gets complex. Kidney Int 67: 1234–1247, 2005 - PubMed
-
- Pei Y: A “two-hit” model of cystogenesis in autosomal dominant polycystic kidney disease? Trends Mol Med 7: 151–156, 2001 - PubMed
-
- Lantinga-Van Leeuwen I, Dauwerse J, Baelde H, Leonhard W, van de Wal A, Ward C, Verbeek S, DeRuiter M, Breuning M, de Heer E, Peters D: Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. Hum Mol Genet 13: 3069–3077, 2004 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
